Lerin C: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
|lastname=Lerin | |lastname=Lerin | ||
|firstname=Carles | |firstname=Carles | ||
| | |institution=August Pi i Sunyer Biomedical Research Institute, | ||
Diabetes and obesity laboratory, | |||
Diabetes and obesity laboratory | |||
IDIBAPS Barcelona | IDIBAPS Barcelona | ||
|city=Barcelona | |||
|country=Spain | |||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
* [ | ==Participated at== | ||
* [[IOC70]] | |||
Revision as of 13:58, 13 June 2016
| Name | Lerin Carles, |
|---|---|
| Institution | August Pi i Sunyer Biomedical Research Institute,
Diabetes and obesity laboratory, IDIBAPS Barcelona |
| Address | , |
| City | Barcelona |
| State/Province | |
| Country | Spain |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Ejaz 2016 Diabetes | 2016 | Ejaz A, Martinez-Guino L, Goldfine AB, Ribas-Aulinas F, De Nigris V, Ribó S, Gonzalez-Franquesa A, Garcia-Roves PM, Li E, Dreyfuss JM, Gall W, Kim JK, Bottiglieri T, Villarroya F, Gerszten RE, Patti ME, Lerin C (2016) Dietary betaine supplementation increases Fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice. Diabetes 65:902-12. |
